AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,557,135 | -14.4% | 36,588 | -12.0% | 0.00% | 0.0% |
Q2 2023 | $2,987,723 | +19.5% | 41,577 | +2.6% | 0.00% | 0.0% |
Q1 2023 | $2,500,199 | -17.1% | 40,535 | +3.7% | 0.00% | -20.0% |
Q4 2022 | $3,015,474 | +83.3% | 39,096 | +6.1% | 0.01% | +66.7% |
Q3 2022 | $1,645,000 | +18.0% | 36,858 | +1.3% | 0.00% | +50.0% |
Q2 2022 | $1,394,000 | +2.4% | 36,391 | +10.6% | 0.00% | 0.0% |
Q1 2022 | $1,361,000 | +0.7% | 32,892 | -8.1% | 0.00% | 0.0% |
Q4 2021 | $1,352,000 | +17.3% | 35,788 | +2.3% | 0.00% | +100.0% |
Q3 2021 | $1,153,000 | -55.4% | 34,979 | -8.7% | 0.00% | -66.7% |
Q2 2021 | $2,584,000 | +9.3% | 38,306 | -8.3% | 0.00% | 0.0% |
Q1 2021 | $2,365,000 | -30.7% | 41,778 | -0.3% | 0.00% | -40.0% |
Q4 2020 | $3,415,000 | +14.2% | 41,917 | -0.1% | 0.01% | 0.0% |
Q3 2020 | $2,990,000 | -13.0% | 41,962 | +0.5% | 0.01% | -16.7% |
Q2 2020 | $3,437,000 | +42.4% | 41,773 | +1.8% | 0.01% | +20.0% |
Q1 2020 | $2,414,000 | -39.2% | 41,041 | +6.8% | 0.01% | -28.6% |
Q4 2019 | $3,973,000 | +400.4% | 38,437 | -2.0% | 0.01% | +250.0% |
Q3 2019 | $794,000 | -17.7% | 39,214 | +4.6% | 0.00% | 0.0% |
Q2 2019 | $965,000 | +846.1% | 37,492 | +43.0% | 0.00% | – |
Q1 2017 | $102,000 | -34.2% | 26,212 | +14.4% | 0.00% | – |
Q4 2016 | $155,000 | -15.3% | 22,912 | -1.3% | 0.00% | – |
Q3 2016 | $183,000 | +4.0% | 23,212 | -0.4% | 0.00% | – |
Q2 2016 | $176,000 | – | 23,312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |